Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer (Q43899648)
Jump to navigation
Jump to search
scientific article published in March 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer |
scientific article published in March 2002 |
Statements
1 reference
Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer (English)
1 reference
Natasha B Leighl
1 reference
Frances A Shepherd
1 reference
Rita Kwong
1 reference
Ronald L Burkes
1 reference
Ronald Feld
1 reference
1 March 2002
1 reference
1 reference
Identifiers
1 reference